Cinolazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401504This classification denotes a benzodiazepine with the molecular formula C18H13ClFN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 68P0556B0U, chemically known as 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1h-1,4-benzodiazepine-1-propionitrile but generally known as cinolazepam, which bears US NIH Compound Identifier 3033621. European Medicines Agency schedules Cinolazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06307MIG. The term CINOLAZEPAM is an International Non-Proprietary Name. World Health Organization schedules cinolazepam in its Anatomical Therapeutic Chemical (ATC) Classification. CINOLAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinolazepam under HS 29339940 and SITC 51577. As of Q4 2014, CINOLAZEPAM remains the US FDA Preferred Term for this commodity. Cinolazepam bears US NLM identifiers UMLS ID C0164835 and NCI Concept Code C77635. SMILES: CLC1CC2C(N(CCC#N)C(=O)C(O)N=C2C2C(F)CCCC2)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.